David Dingli

Improved survival in multiple myeloma and the impact of novel therapies

Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri et al. · Blood · 2007 · 2.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Leukemia · 2013 · 1.4K citations · Full text

Medicine, Geriatric Medicine, Oncology +12

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

Medicine, Cardiology, Pathology +15

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

Shaji Kumar, Joseph Mıkhael, Francis K. Buadi et al. · Mayo Clinic Proceedings · 2009 · 625 citations · Full text

Medicine, Hematology, Oncology +14